Targeting Metastasis, transforming treatment
Metsystem develops METscreen, an advanced drug screen platform using patient-derived organoids and metastasis-targeting technologies to predict if and where cancer will spread and identify the most effective treatment for each patient. By bridging cutting-edge science with clinical application, Metsystem empowers doctors to make precise, informed treatment decisions based on the cancer's actual response.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountNo funding data available yet.
Know something? Help us improve our data.
Create a free account to see which investors have funded this company.
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
Healthcare company in Europe
Mehiläinen is a leading Finnish private healthcare company providing medical, health, and special...
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
Klick Health is a healthcare marketing and commercialization agency serving life sciences and pha...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
